Mercy Medical Center - The Institute for Digestive Health and Liver Disease
Baltimore, Maryland, United States
Gastroenterologist in Baltimore, Maryland
301 St Paul Pl, Baltimore, MD 21202
About Mercy Medical Center - The Institute for Digestive Health and Liver Disease
"From more common digestive tract diagnoses such as heartburn and colorectal disease to complex diagnoses for liver cancer and pancreatic cancer, Mercy Medical Center and The Institute for Digestive Health & Liver Disease offer patients a comprehensive and coordinated approach, aiming to continue to be one of the best Gastroenterology Centers in Baltimore and the Mid-Atlantic region. The dedicated physician team works to provide the best treatment options available for digestive disorders. The Center's top specialists provide advanced therapies, education and surgical treatment options that are ranked among the best available in the United States. Academic and research leadership drives our doctors to actively participate in research and c"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Mercy Medical Center - The Institute for Digestive Health and Liver Disease
During the past decade, Mercy Medical Center - The Institute for Digestive Health and Liver Disease conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
1995-12-01
2010-02-01
Completed
2,411
Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
1999-03-01
2012-12-01
Completed
5,351
Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer
1999-05-01
2014-02-01
Completed
5,611
ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer
1999-02-01
2008-09-22
Completed
22
Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
2000-02-01
2019-11-01
Completed
2,130
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
2001-05-01
2011-02-01
Completed
1,598
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome
2004-06-01
2012-02-01
Completed
806
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Mercy Medical Center - The Institute for Digestive Health and Liver Disease
According to Clinical.Site data, the most researched conditions in "Mercy Medical Center - The Institute for Digestive Health and Liver Disease" are
"NASH - Nonalcoholic Steatohepatitis" (2 trials), "Biliary Cirrhosis, Primary" (1 trials), "Cirrhosis" (1 trials), "Hepatocellular Cancer" (1 trials) and "Prevention of Esophageal Varices" (1 trials). Many other conditions were trialed in "Mercy Medical Center - The Institute for Digestive Health and Liver Disease" in a lesser frequency.
Clinical Trials Intervention Types at Mercy Medical Center - The Institute for Digestive Health and Liver Disease
Most popular intervention types in "Mercy Medical Center - The Institute for Digestive Health and Liver Disease" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "HM15211" (1 trials), "Placebo" (1 trials), "Placebo of HM15211" (1 trials) and "belapectin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Mercy Medical Center - The Institute for Digestive Health and Liver Disease
The vast majority of trials in "Mercy Medical Center - The Institute for Digestive Health and Liver Disease" are
4 trials for "All" genders.
Clinical Trials Status at Mercy Medical Center - The Institute for Digestive Health and Liver Disease
Currently, there are NaN active trials in "Mercy Medical Center - The Institute for Digestive Health and Liver Disease".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Mercy Medical Center - The Institute for Digestive Health and Liver Disease,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Mercy Medical Center - The Institute for Digestive Health and Liver Disease, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".